AU756882B2 - New contraceptive kit - Google Patents

New contraceptive kit Download PDF

Info

Publication number
AU756882B2
AU756882B2 AU31437/99A AU3143799A AU756882B2 AU 756882 B2 AU756882 B2 AU 756882B2 AU 31437/99 A AU31437/99 A AU 31437/99A AU 3143799 A AU3143799 A AU 3143799A AU 756882 B2 AU756882 B2 AU 756882B2
Authority
AU
Australia
Prior art keywords
compound
contraceptive
pharmaceutically acceptable
structural formula
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31437/99A
Other languages
English (en)
Other versions
AU3143799A (en
Inventor
Herman Jan Tijmen Coelingh Bennink
Godefridus Hermanus Johanna Deckers
Johannes Antonius Maria Hamersma
Helenius Jan Kloosterboer
Pieter Michiel Verbost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU3143799A publication Critical patent/AU3143799A/en
Application granted granted Critical
Publication of AU756882B2 publication Critical patent/AU756882B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU31437/99A 1998-03-09 1999-03-03 New contraceptive kit Ceased AU756882B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09
EP98200744 1998-03-09
PCT/EP1999/001404 WO1999045886A2 (en) 1998-03-09 1999-03-03 New contraceptive kit for monotherapy

Publications (2)

Publication Number Publication Date
AU3143799A AU3143799A (en) 1999-09-27
AU756882B2 true AU756882B2 (en) 2003-01-23

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31437/99A Ceased AU756882B2 (en) 1998-03-09 1999-03-03 New contraceptive kit

Country Status (20)

Country Link
EP (1) EP1061928A2 (xx)
JP (1) JP2002506014A (xx)
KR (1) KR20010041698A (xx)
CN (1) CN1292702A (xx)
AR (1) AR018313A1 (xx)
AU (1) AU756882B2 (xx)
BR (1) BR9908605A (xx)
CA (1) CA2319765A1 (xx)
CO (1) CO5070598A1 (xx)
HU (1) HUP0101007A3 (xx)
ID (1) ID25621A (xx)
IL (1) IL137541A0 (xx)
NO (1) NO20004492L (xx)
NZ (1) NZ506115A (xx)
PE (1) PE20000330A1 (xx)
PL (1) PL343428A1 (xx)
RU (1) RU2225714C2 (xx)
TR (1) TR200002593T2 (xx)
WO (1) WO1999045886A2 (xx)
ZA (1) ZA991851B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051214A2 (en) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
AU770331B2 (en) * 1999-09-06 2004-02-19 N.V. Organon Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
PL366235A1 (en) 2000-07-28 2005-01-24 Akzo Nobel N.V. 16alpha-methyl or ethyl substituted estrogens
CA2478206A1 (en) * 2002-03-11 2003-09-25 Patrick Michel Caubel Sulfatase inhibiting continuous progestogen contraceptive regimens
AU2003222273A1 (en) * 2002-03-11 2003-09-29 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292251A (en) * 1977-02-10 1981-09-29 Akzona Incorporated 11β-Substituted steroids
WO1994018224A1 (en) * 1993-02-08 1994-08-18 Akzo Nobel N.V. Steroids for treating menopausal complaints

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292251A (en) * 1977-02-10 1981-09-29 Akzona Incorporated 11β-Substituted steroids
WO1994018224A1 (en) * 1993-02-08 1994-08-18 Akzo Nobel N.V. Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
NO20004492D0 (no) 2000-09-08
NZ506115A (en) 2003-07-25
HUP0101007A2 (hu) 2001-12-28
WO1999045886A2 (en) 1999-09-16
RU2225714C2 (ru) 2004-03-20
JP2002506014A (ja) 2002-02-26
NO20004492L (no) 2000-09-08
CN1292702A (zh) 2001-04-25
WO1999045886A3 (en) 1999-12-02
KR20010041698A (ko) 2001-05-25
ZA991851B (en) 1999-09-22
ID25621A (id) 2000-10-19
AU3143799A (en) 1999-09-27
PE20000330A1 (es) 2000-05-16
BR9908605A (pt) 2001-04-24
HUP0101007A3 (en) 2002-02-28
EP1061928A2 (en) 2000-12-27
AR018313A1 (es) 2001-11-14
CA2319765A1 (en) 1999-09-16
IL137541A0 (en) 2001-07-24
CO5070598A1 (es) 2001-08-28
PL343428A1 (en) 2001-08-13
TR200002593T2 (tr) 2000-12-21

Similar Documents

Publication Publication Date Title
JP4023820B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体を含有する医薬製剤
AU687000B2 (en) Contraception method using competitive progesterone antagonists and novel compounds useful therein
JP4368945B2 (ja) 新規１９―ノループレグネン誘導体類
EP1272505B1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
JP3814292B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体、これらの製造方法及びこれら化合物を含有する製薬組成物
EP0912186A1 (en) Progestogen-anti-progestogen regimens
EP2285383A2 (de) Sequentielle verarbeitung von 20,20,21,21-pentafluor-17-hydroxy-11 -ý4-(hydroxyacetyl) phenyl¨-19-nor-17 -pregna-4,9-dien-3-on und einem oder mehreren gestagenen zur behandlung gynäkologischer erkrankungen
US4027019A (en) 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
AU756882B2 (en) New contraceptive kit
CA2384184C (en) 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
JP6486900B2 (ja) プロゲステロン受容体アンタゴニスト剤形
IE872217L (en) 14,17-beta-ethano-14-beta-estratrienes and estratetraenes
CA2309745A1 (en) Progestogen-antiprogestogen regimens
MXPA00008814A (en) New contraceptive kit
CZ20003285A3 (cs) Antikoncepční sada
US3816406A (en) O-aryl oximes of 3-keto steroids
US3644330A (en) Derivatives of estradiol-17beta-glucosides

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)